Search
Results
showing 1-10 of 2347
Ensuring the future of clinical trials networks
November 2026
After months of delays by the US Administration, and relentless advocacy by researchers, advocates and communities including the Save HIV Funding campaign, NIH finally published the Notices of Funding Opportunity (NOFOs) for the next cycle of the HIV Clinical Trials Networks (CTNs). Today is a welcome step forward after many months of unnecessary political delay by an administration bent on dismantling US global scientific leadership and partnerships. But it’s not the end of the story, and analysis is underway now. On initial read, it is notable that international sub-awards are not allowed, diminishing the research power of the networks. Funding amounts seemingly remain relatively flat after seven years, but would represent a decline in real-terms, given biomedical research inflation.
Global Health Watch: Congress signals support for global health + research, US loses measles elimination status, NIAID new director
November 2026
Signs of Congressional pushback against the US Administration’s health and science agenda emerged this week as new funding bills were introduced, while nominations to lead the US FDA and National Science Foundation were rescinded. Meanwhile, the US lost its measles elimination status, and NIAID appointed a new director.
LEN for PrEP: Lessons from Three Early Adopter Countries
November 2026
Since December 2025, lenacapavir (LEN) for PrEP has been introduced in 10 African countries, hitting introduction milestones with record speed. AVAC, with support from the US Bureau of Global Health Security and Diplomacy (GHSD), partnered with Lvcthealth in Kenya, Pakachere Institute of Health and Development Communication in Malawi, and HEPS-Uganda, along with Ministries of Health (MoH) and the US Embassies in the three countries, to advance community-led demand generation, capacity-building and evidence-informed implementation to speed product introduction.
Advancing Access to LEN for PrEP
November 2026
Working with Ministries of Health (MoH), civil society and key stakeholders to support community-centered, strategic planning and rollout of LEN for PrEP in three early adopter countries.
Advancing Access to LEN for PrEP
November 2026
AVAC is pleased to share, Advancing Access to LEN for PrEP, highlighting the approaches that led to strong, sustainable, community-centered LEN introductions in Kenya, Malawi and Uganda. It documents the lessons learned and shares resources that can help other countries determine how to effectively prepare for and deliver LEN and future PrEP options.
Building Public Trust Through Evidence-Based Media Engagement
November 2026
To strengthen the quality of public communication on HIV prevention, HEPS-Uganda partnered with the Ministry of Health and the Health Journalists Network of Uganda (HEJNU) to convene regional Media Science Cafés focused on HIV prevention, bringing together 86 journalists and media practitioners from across the country. The engagements created a platform for direct dialogue and stronger ongoing collaboration between journalists, HIV researchers, clinicians, program implementers and policy makers – enabling media professionals to deepen their understanding of LEN and other PrEP options, and Uganda’s national rollout strategy.
Community involvement in materials design increases awareness of and demand for LEN and PrEP choice among priority populations
November 2026
As part of a project to provide technical support to the Ministry of Health around LEN introduction, Pakachere led the development of awareness and demand-generation materials for LEN and PrEP choice. This work was designed and conducted using a highly consultative process in collaboration with the National AIDS Commission (NAC). To reinforce the CHOICE approach, which centers the user and promotes access to PrEP options, LEN messaging was seamlessly integrated into adapted materials previously developed for oral PrEP and cabotegravir (CAB).
Supporting the Ministry of Health to implement LEN in-country
November 2026
In advance of LEN rollout in Kenya, Lvcthealth worked closely with NASCOP and county HIV teams, to support planning and preparations at the country and facility level. Along with support to build community demand and trust, Lcvthealth provided technical support to strengthen service delivery through the development of technical assistance (TA) tool used to guide supportive supervision and TA visits across 10 counties, and directly conducting targeted supervision in Nakuru and Kiambu counties to extend technical support to these priority areas.
Advancing Access to LEN for PrEP in Kenya, Malawi and Uganda: Communications Toolkit
November 2026
These communication materials were created during the Advancing Access to LEN for PrEP projects in Kenya, Malawi and Uganda. Partners worked with government and communities to develop tailored materials to raise awareness of LEN for PrEP, situating it among other available prevention options as a way of facilitating informed choice. Across the three countries, 36 demand-generation materials were developed with community input.
Global Health Watch: What a New US Congress Could Mean for Science + Global Health, America First Global Health Strategy, Measles Resurgence
November 2026
The wave of newly elected US lawmakers with backgrounds in science and global health offers new opportunities for advocacy and oversight; a ProPublica exposé reveals nearly $40 million in federal health security awards to a company linked to the US President’s family amid the rollout of the “America First Global Health Strategy”; and the potential loss of US measles elimination status underscores the consequences of eroding trust in science and the spread of disinformation.
showing 1-10 of 2347